Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

WSE/SNT stock hub

WSE/SNT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

WSE/SNTis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.4B
Warsaw Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
WSE/SNT
In the news

Latest news · WSE/SNT

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15
P25 n/aP50 n/aP75 n/a
Trailing P/E18.2
P25 n/aP50 n/aP75 n/a
ROE55.1
P25 n/aP50 n/aP75 n/a
ROIC88.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All WSE/SNT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
236
Groups with data
11
Currency
PLN
Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Poland
Country code
PL
Employees
231
Employees Change
52%
Employees Change Percent
29.05
Enterprise value
PLN 2.3B
Exchange
Warsaw Stock Exchange
Financial currency
PLN
First seen
2026-05-10
Industry
Medical Devices
Isin
PLSNKTK00019
Last refreshed
2026-05-10
Market cap
PLN 2.4B
Price
PLN 283
Price currency
PLN
Rev Per Employee
3,058,213.29x
Sector
Healthcare
Sic
7370
Symbol
wse/SNT
Website
https://www.synektik.com.pl

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
4.35%
EV Earnings
21.73x
EV/EBIT
13.58x
EV/EBITDA
12.11x
EV/FCF
44.7x
EV/Sales
3.22x
FCF yield
2.11%
Forward P/E
15.04x
P/B ratio
9.33x
P/E ratio
18.18x
P/S ratio
3.41x
PE Ratio10 Y
173.8x
PE Ratio3 Y
17.38x
PE Ratio5 Y
20.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
23.66%
EBITDA Margin
25.58%
FCF margin
7.21%
Gross margin
36.62%
Gross Profit
PLN 258.7M
Gross Profit Growth
30.43%
Gross Profit Growth Q
24.23%
Gross Profit Growth3 Y
49.93%
Gross Profit Growth5 Y
53.05%
Net Income
PLN 104.8M
Net Income Growth
29.31%
Net Income Growth Q
5.56%
Net Income Growth Quarters
4%
Net Income Growth Years
4%
Net Income Growth3 Y
55.98%
Net Income Growth5 Y
60.19%
Pretax Margin
23.3%
Profit Margin
14.83%
Profit Per Employee
PLN 453,549
Profitable Years
10
ROA
19.16
Roa5y
14.17
ROCE
52.18
ROE
55.07
Roe5y
38.43
ROIC
88.39
Roic5y
50.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

27
MetricValue
Cagr10y
36.21%
Cagr1y
26.53%
Cagr3y
74.43%
Cagr5y
60.91%
Div CAGR3
52.52%
Div CAGR5
88.64%
EPS Growth
29.31
EPS Growth Q
5.6
EPS Growth Quarters
4
EPS Growth Years
4
EPS Growth3 Y
55.98
EPS Growth5 Y
60.32
FCF Growth
40.31%
FCF Growth Q
-9.46%
FCF Growth3 Y
86.28%
FCF Growth5 Y
36.74%
OCF Growth
-14.9%
OCF Growth Q
-11.45%
OCF Growth10 Y
11.28%
OCF Growth3 Y
53.99%
OCF Growth5 Y
33.78%
Revenue Growth
27.07x
Revenue Growth Q
12.23x
Revenue Growth Quarters
4x
Revenue Growth Years
5x
Revenue Growth3 Y
36.91x
Revenue Growth5 Y
42.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
PLN 1.3
Assets
PLN 605.4M
Cash
PLN 166.2M
Current Assets
PLN 445.6M
Current Liabilities
PLN 285.1M
Debt
PLN 32.4M
Debt EBITDA
PLN 0.17
Debt Equity
PLN 0.13
Debt FCF
PLN 0.64
Equity
PLN 258.3M
Interest Coverage
49.45
Liabilities
PLN 347M
Long Term Assets
PLN 159.7M
Long Term Liabilities
PLN 61.9M
Net Cash
PLN 133.9M
Net Cash By Market Cap
PLN 5.55
Net Cash Growth
-19.8%
Net Debt EBITDA
PLN -0.74
Net Debt Equity
PLN -0.52
Net Debt FCF
PLN -2.63
Tangible Book Value
PLN 219.5M
Tangible Book Value Per Share
PLN 25.74
WACC
7.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.56
Inventory Turnover
6.45
Net Working Capital
PLN 3.6M
Quick ratio
1.13
Working Capital
PLN 160.5M
Working Capital Turnover
PLN 5.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Dividend Growth
30.3%
Dividend Growth Years
3%
Dividend per share
PLN 10.75
Dividend Years
7
Dividend Yield
3.8%
Ex Div Date
2026-04-02
Last Dividend
PLN 10.75
Payout Frequency
Annual
Payout Ratio
67.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
2,097.46%
1Y total return
26.51%
200-day SMA
266.2
3Y total return
430.89%
50-day SMA
286.1
50-day SMA vs 200-day SMA
50over200
5Y total return
978.33%
All Time High
317
All Time High Change
-10.85%
All Time High Date
2026-01-12
All Time Low
5.76
All Time Low Change
4,806.25%
All Time Low Date
2011-08-09
ATR
8.22
Beta
0.63
Beta1y
0.77
Beta2y
0.73
High
286.4
High52
317
High52 Date
2026-01-12
High52ch
-10.85%
Low
282.4
Low52
180.2
Low52 Date
2025-07-01
Low52ch
56.83%
Ma50ch
-1.22%
Price vs 200-day SMA
6.15%
RSI
43.35
RSI Monthly
70.81
RSI Weekly
52.52
Sharpe ratio
0.78x
Sortino ratio
1.23
Total Return
3.8%
Tr YTD
3.68
Tr1m
-0.56%
Tr1w
-2.35%
Tr3m
-5.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
PLN 167.1M
Operating Income Growth
31.02
Operating Income Growth Q
18.22
Operating Income Growth3 Y
69.93
Operating Income Growth5 Y
66.36
Operating margin
23.66

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
5,005,606%
Net Borrowing
2,288,776
Shares Insiders
17.31%
Shares Institutions
8.79%
Shares Out
8,529,129
Shares Qo Q
0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
PLN 50.9M
Average Volume
23,296.55x
Bv Per Share
30.29
CAPEX
PLN -14.8M
Ch10y
1,764.1
Ch1m
-0.56
Ch1w
-2.35
Ch1y
22.02
Ch3m
-5.48
Ch3y
382.3
Ch5y
851.5
Ch6m
7.29
Change
-0.42%
Change From Open
-0.49
Close
283.8
Days Gap
0.07
Depreciation Amortization
13,623,887
Dollar Volume
3,223,053
Earnings Date
2026-06-11
EBIT
PLN 167.1M
EBITDA
PLN 180.7M
EPS
PLN 12.28
F Score
6
FCF
PLN 50.9M
FCF EV Yield
2.24x
FCF Per Share
PLN 5.97
Financing CF
-70,525,126
Fiscal Year End
September
Founded
2,001
Goodwill
3,645,710
Graham Number
91.49574
Graham Upside
-67.62
Income Tax
PLN 32M
Investing CF
-16,468,930
Is Primary Listing
1
Last Earnings Date
2026-02-12
Last Report Date
2025-12-31
Lynch Fair Value
PLN 307
Lynch Upside
8.67
Ma150
279.8
Ma150ch
0.98%
Ma20
291.9
Ma20ch
-3.17%
Net CF
-21,257,999
Next Earnings Date
2026-06-11
Open
284
P FCF Ratio
47.33
P OCF Ratio
36.67
Payment Date
2026-02-02
Position In Range
5
Ppne
81,145,600
Price Date
2026-05-08
Price EBITDA
PLN 13.34
Ptbv Ratio
10.98
Relative Volume
0.49x
Revenue
706,447,271x
Tax By Revenue
4.53x
Tax Rate
19.44%
Tr6m
11.23%
Volume
11,405
Z Score
6.21
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

WSE/SNT dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.8%
$10.8 annual per share
Payout ratio
+67.2%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+88.6%
3 consecutive years of growth
Total shareholder yield
+3.8%
Next ex-dividend date: 2026-04-02
Performance

WSE/SNT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+26.5%
S&P 500 1Y: n/a
3Y total return
+430.9%
S&P 500 3Y: n/a
5Y total return
+978.3%
S&P 500 5Y: n/a
10Y total return
+2097.5%
S&P 500 10Y: n/a
Ownership

Who owns WSE/SNT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+8.8%
Share of float held by funds and institutions
Insider ownership
+17.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

WSE/SNT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
43.3
Neutral momentum band
Price vs 200-day MA
+6.2%
50/200-day relationship not available
Beta (5Y)
0.63
Less volatile than the market
Sharpe ratio
0.78
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About WSE/SNT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/SNT stock rating?

wse/SNT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/SNT analysis?

The full report lives at /stocks/wse/SNT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/SNT?

The latest report frames wse/SNT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/SNT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.